Search This Blog

Wednesday, August 1, 2018

United Therapeutics reports Q2 EPS $4.36, consensus $3.16


Reports Q2 revenue $444.5M, consensus $368.58M.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.